Document is current
Any future updates will be listed below
-
Authors
Harripaul, Ricardo
Rabia, Ansa
Vasli, Nasim
Mikhailov, Anna
Rodrigues, Ashlyn
Pastore, Stephen F.
Muhammad, Tahir
Madanagopal, Thulasi Thiruvallur
Hashmi, Aisha Nasir
Tran, Clinton
Stan, Cassandra
Aw, Katherine
Zai, Clement C.
Azam, Maleeha
Mahmood, Saqib
Heidari, Abolfazl
Qamar, Raheel
French, Leon
Tripathy, Shreejoy
Agha, Zehra
Iqbal, Muhammad
Ghadami, Majid
Santangelo, Susan L.
Bozorgmehr, Bita
Al Ayadhi, Laila
Sasanfar, Roksana
Maqbool, Shazia
Hassan, Arsalan
Knowles, James A.
Ayub, Muhammad
Vincent, John B.
-
Funding
Funding for this research was provided by:
Pakistani Higher Education Commission
Brain Research Foundation
Canadian Institutes of Health Research (#PJT-156402)
Canadian Institutes of Health Research (#PJT-156402)
- License Information
-
More Information
Article History
Received: 12 June 2025
Accepted: 10 March 2026
First Online: 21 March 2026
Declarations
:
: L.F. owns shares in Quince Therapeutics and has received consulting fees from PeopleBio Co., GC Therapeutics Inc., Cortexyme Inc., and Keystone Bio. M.Ayub is co-founder and director of Institute of Omics and Health Research, Lahore, a research organization. The organization was not involved in the research on which this manuscript is based. All other authors declare no competing interests.
